the beta-blocker heart attack trial ( bhat ) was a multicenter , randomized , double-blind , placebo-controlled trial that tested the effectiveness of propranolol in reducing the mortality rate in patients after myocardial infarction ( mi ) .
C0033497
propranolol
C0027051
myocardial